Funding for this research was provided by:
The National Key R&D Program of China (2019YFD0901805)
The 111 Project (B18022)
Fundamental Research Funds for Central Universities of the Central South University
The Open Project Funding of the State Key Laboratory of Bioreactor Engineering, ECUST (ZDXM2019)
Received: 16 November 2021
Accepted: 22 January 2022
First Online: 11 February 2022
: The pharmacokinetic study was approved by the Institutional Animal Care and Use Committees of SHCQ (Permit Number SHCQ-20200032).
: All authors have read this article and have approved its submission to <i>Bioresources and Bioprocessing</i>.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.